Stroke in sickle cell disease patients: Transcranial Doppler and magnetic resonance imaging;Accidents vasculaires cérébraux des drépanocytaires: Apport du Doppler transcrânien et de l'imagerie en résonance magnétique

Hematologie

Volumn 14, Issue 1, 2008, Pages 25-35

  Bernaudin, Françoise ^a   Verlhac, Suzanne ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Cerebral vasculopathy; MRA; MRI; Sickle cell disease; Stem cell transplantation; Transcranial Doppler; Transfusion

Indexed keywords

BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INCIDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION; STROKE; SURVIVAL; VASCULAR DISEASE;

EID: 41549161120     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: 10.1684/hma.2008.0209     Document Type: Review

References (46)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease : rates and risk factors. Blood 1998 ; 91 : 288-94.
2. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease : Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998 ; 51 : 169-76.
3. Bernaudin F, Verlhac F, Fréard F, et al. Multicenter prospective study of children with sickle cell disease : radiographic and psychometric correlation PHRC 95. J Child Neurol 2000 ; 15 : 333-43.
4. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease : a report from the Cooperative Study of Sickle Cell Disease. Am J Neuro 1996 ; 17 : 965-72.
5. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children cell disease. Blood 2002 ; 99 : 3014-8.
6. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949 ; 110 : 543-6.
7. Ingram VM. Gene mutation in human hemoglobin : the chemical difference between normal and sickle cell hemoglobin. Nature 1957 ; 180 : 326-9.
8. Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. Hematology (Am Soc Hematol Educ Program) 2000 : 2-17.
9. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease : reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007 ; 21 : 37-47.
10. Powars ER, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med 1978 ; 65 : 461-71.
11. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia : magnetic resonance imaging correlates. Ann Neurol 1988 ; 23 : 125-30.
12. Pavlakis SG, Prohovnik I, Piomelli S, DeVivo DC. Neurologic complications of Sickle Cell Disease. Adv Pediatr 1989 ; 36 : 247-76.
13. Adams RJ, Ohene-Frempong K, Wang W. Sickle cell and the brain. Hematology (Am Soc Hematol Educ Program) 2001 : 31-46.
14. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle cell disease : present and future. Lancet Neurol 2006 ; 5 : 501-12.
15. Adams RJ, Nichols T, McKie K, Milner P, Gammal TE. Cerebral infarction in sickle cell anemia mechanism based on CT and MRI. Neurology 1988 ; 38 : 1012-7.
16. Bernaudin F, Freard F, Verlhac S, et al. Analyse finale de l'étude prospective, multicentrique concernant les fonctions cognitives du jeune drépanocytaire : relation avec les données biologiques et neuroradiologiques (PHRC 95). Hématologie 2000 ; 6 ; (Abstract 53).
17. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in Sickle Cell Disease. Blood 1984 ; 63 : 162-9.
18. Bernaudin F, Verlhac S, Socié G, et al. Cerebral vasculopathy outcome after stem cell transplantation for sickle cell disease. Bone Marrow Transplant 2007 ; 39(Suppl. 1) : S35.
19. Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999 ; 94 : 3022-6.
20. Bernaudin F, Verlhac S, Brugieres P, Lesprit E, Reinert P. Early cerebral exploration with transcranial Doppler (TCD) in patients with sickle cell disease (SCD) : effects of age and risk factors on velocities. Blood 2001 ; 98(Abstract 3261) : 784a.
21. Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet 2001 ; 357 : 1656-9.
22. Driscoll M, Hurlet A, Styles L, et al. Stroke risk in siblings with sickle cell anemia. Blood 2003 ; 101 : 2401-4.
23. Styles LA, Hoppe C, Klitz W, et al. Evidence for HLA-related suceptibility for stroke in children with sickle cell disease Blood 2000 ; 95 : 3562-7.
24. Hoppe C, Klitz W, Cheng S, et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004 ; 103 : 2391-6.
25. Bernaudin F, Socié G, Kuentz M, et al. Long term results of related myeloablative stem-cell transplantation 10 cure sickle cell disease. Blood 2007 ; 110 : 2749-56.
26. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children cell disease. Blood 2002 ; 99 : 3014-8.
27. Bernaudin F, Verlhac S, Coïc L, et al. Efficacité de l'exploration précoce par doppler transcrânien dans la prévention des accidents vasculaires cérébraux : expérience monocentrique d'une cohorte d'enfants drépanocytaires dépistés en néonatal. Hématologie 2007 ; 13(Suppl. 2) : 29 ; (abstract 03-27).
28. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia : a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001 ; 139 : 385-90.
29. Kinney TR, Sleeper LA, Wang WC. Silent cerebral infarcts in sickle cell anemia : a risk factor analysis. Pediatrics 1999 ; 103 : 640-5.
30. Adams RJ, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992 ; 326 : 605-10.
31. Verlhac S, Bernaudin F, Tortrat D, et al. Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography : correlation with MRI, MRA and conventional angiography. Pediatr Radiol 1995 ; 25 : S14-S19.
32. Verlhac S, Bernaudin F, Brugieres P. Doppler transcrânien couleur chez les enfants drépanocytaires. J Radiol 2003 ; 84 : 131-8.
33. Adams R, McKie V, Hsu L, et al. Prevention of a first stroke by transfusion in children with sickle cell anemia and abnormal results of transcranial Doppler ultrasonography. N Engl J Med 1998 ; 339 : 5-11.
34. Bernaudin F, Verlhac S, Lesprit E, et al. Etude des facteurs prédictifs de survenue de la vasculopathie cérébrale chez les enfants drépanocytaires à partir d'une exploration systématique annuelle et précoce par doppler transcrânien (DTC). Hématologie 2002 ; 32 ; (abstract 53).
35. Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T. Transcranial Doppler Correlation with Cerebral Angiography in Sickle Cell Disease. Stroke 1992 ; 23 : 1073-7.
36. Seibert JJ, Glasier CM, Kirby RS, et al. TCD MRA and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia : an 8 year study. Pediatr Radiol 1998 ; 28 : 138-42.
37. Adams RJ, McKie VC, Carl EM, et al. Long term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997 ; 42 : 699-704.
38. Kwiatkowski JL, Granger S, Brambilla DJ, Brown RC, Miller ST, Adams RJ. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease : extended analysis from the STOP trial. Br J Haematol 2006 ; 134 : 333-9.
39. Abboud MR, Cure J, Granger S, et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004 ; 103 : 2822-6.
40. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in Sickle Cell Disease. N Engl J Med 2005 ; 353 : 2769-78.
41. Minniti CP, Gidvani VK, Bulas D, Brown WA, Vezina G, Driscoll C. Transcranial Doppler changes in chikdren with sickle cell disease on transfusion therapy. J Pediatr Hematol Oncol 2004 ; 26 : 626-30.
42. Bernaudin F, Verlhac S, Coic L, Lesprit E, Brugieres P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol 2005 ; 35 : 242-8.
43. Fullerton H, Johnston SC, Zhao S, et al. Declining Rates in Californian children with Sickle Cell Disease. Blood 2004 ; 104 : 336-9.
44. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004 ; 103 : 4023-7.
45. Wiznitzer M, Ruggieri P, Masaryk T, Ross J, Modic M, Berman B. Diagnosis or cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr 1990 ; 117 : 551-5.
46. Recommandations de l'HAS : http://www.hassante.fr/ portail/upload/docs/ application/pdf/Drepanocytose_reco.pdf